EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $27,000 | -99.1% | 18,194 | -99.3% | 0.00% | – |
Q1 2022 | $3,017,000 | +39.4% | 2,623,632 | +203.2% | 0.00% | – |
Q4 2021 | $2,164,000 | -76.5% | 865,373 | -51.9% | 0.00% | -100.0% |
Q3 2021 | $9,217,000 | -38.5% | 1,800,117 | -0.2% | 0.00% | 0.0% |
Q2 2021 | $14,986,000 | -4.8% | 1,803,378 | -0.3% | 0.00% | 0.0% |
Q1 2021 | $15,748,000 | -12.7% | 1,808,079 | +8.8% | 0.00% | -50.0% |
Q4 2020 | $18,046,000 | -24.8% | 1,661,672 | -17.4% | 0.00% | 0.0% |
Q3 2020 | $23,986,000 | -25.8% | 2,010,563 | -0.2% | 0.00% | -50.0% |
Q2 2020 | $32,341,000 | +3.5% | 2,013,786 | -0.1% | 0.00% | 0.0% |
Q1 2020 | $31,261,000 | -43.2% | 2,015,514 | -9.8% | 0.00% | -33.3% |
Q4 2019 | $54,989,000 | +100.1% | 2,235,322 | -16.1% | 0.01% | +100.0% |
Q3 2019 | $27,487,000 | -31.7% | 2,664,812 | -16.9% | 0.00% | -40.0% |
Q2 2019 | $40,228,000 | -6.8% | 3,205,413 | -8.0% | 0.01% | 0.0% |
Q1 2019 | $43,169,000 | +101.8% | 3,484,137 | +0.3% | 0.01% | +66.7% |
Q4 2018 | $21,390,000 | -45.0% | 3,472,378 | -5.3% | 0.00% | -25.0% |
Q3 2018 | $38,861,000 | -53.0% | 3,666,203 | -39.9% | 0.00% | -60.0% |
Q2 2018 | $82,617,000 | -37.3% | 6,097,213 | -17.9% | 0.01% | -37.5% |
Q1 2018 | $131,799,000 | +39.4% | 7,425,339 | -1.4% | 0.02% | +45.5% |
Q4 2017 | $94,517,000 | -51.2% | 7,531,194 | -25.9% | 0.01% | -52.2% |
Q3 2017 | $193,697,000 | +126.1% | 10,167,818 | +79.2% | 0.02% | +109.1% |
Q2 2017 | $85,660,000 | -28.5% | 5,672,872 | -18.8% | 0.01% | -26.7% |
Q1 2017 | $119,886,000 | +21.3% | 6,990,459 | -14.4% | 0.02% | +15.4% |
Q4 2016 | $98,812,000 | +23.0% | 8,166,247 | 0.0% | 0.01% | +18.2% |
Q3 2016 | $80,356,000 | -3.9% | 8,166,247 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $83,622,000 | -12.2% | 8,166,247 | +3.9% | 0.01% | -15.4% |
Q1 2016 | $95,242,000 | -3.8% | 7,858,233 | +27.1% | 0.01% | 0.0% |
Q4 2015 | $99,015,000 | +24.6% | 6,180,700 | 0.0% | 0.01% | +18.2% |
Q3 2015 | $79,484,000 | -46.4% | 6,180,700 | 0.0% | 0.01% | -42.1% |
Q2 2015 | $148,337,000 | +47.2% | 6,180,700 | +15.2% | 0.02% | +46.2% |
Q1 2015 | $100,782,000 | +21.6% | 5,366,439 | +22.2% | 0.01% | +18.2% |
Q4 2014 | $82,872,000 | -29.9% | 4,391,746 | +0.7% | 0.01% | -31.2% |
Q3 2014 | $118,192,000 | -2.6% | 4,359,731 | +11.8% | 0.02% | 0.0% |
Q2 2014 | $121,366,000 | +42.1% | 3,899,931 | +4.0% | 0.02% | +33.3% |
Q1 2014 | $85,390,000 | +105.6% | 3,750,109 | +87.8% | 0.01% | +100.0% |
Q4 2013 | $41,535,000 | -10.0% | 1,996,883 | +73.6% | 0.01% | -14.3% |
Q3 2013 | $46,169,000 | +42.7% | 1,150,483 | 0.0% | 0.01% | +40.0% |
Q2 2013 | $32,363,000 | – | 1,150,483 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |